Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Meloxicam Market, by Region, 2020-2028 (USD Billion)
1.2.2. Meloxicam Market, by Diseases, 2020-2028 (USD Billion)
1.2.3. Meloxicam Market, by Drug Type, 2020-2028 (USD Billion)
1.2.4. Meloxicam Market, by Population Type, 2020-2028 (USD Billion)
1.2.5. Meloxicam Market, by Dosage, 2020-2028 (USD Billion)
1.2.6. Meloxicam Market, by Dose Strength, 2020-2028 (USD Billion)
1.2.7. Meloxicam Market, by End-Users, 2020-2028 (USD Billion)
1.2.8. Meloxicam Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meloxicam Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meloxicam Market Dynamics
3.1. Meloxicam Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.2. Market Challenges
3.1.2.1. Rising preference of NSAIDs over other pain killers
3.1.3. Market Opportunities
3.1.3.1. Rising prevalence of chronic inflammatory and pain diseases
Chapter 4. Global Meloxicam Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Meloxicam Market, by Diseases
6.1. Market Snapshot
6.2. Global Meloxicam Market by Diseases, Performance - Potential Analysis
6.3. Global Meloxicam Market Estimates & Forecasts by Diseases 2019-2028 (USD Billion)
6.4. Meloxicam Market, Sub Segment Analysis
6.4.1. Osteoarthritis
6.4.2. Rheumatoid Arthritis
6.4.3. Juvenile Rheumatoid Arthritis
6.4.4. Others
Chapter 7. Global Meloxicam Market, by Drug Type
7.1. Market Snapshot
7.2. Global Meloxicam Market by Drug Type, Performance - Potential Analysis
7.3. Global Meloxicam Market Estimates & Forecasts by Drug Type 2019-2028 (USD Billion)
7.4. Meloxicam Market, Sub Segment Analysis
7.4.1. Generic
7.4.2. Branded
Chapter 8. Global Meloxicam Market, by Population Type
8.1. Market Snapshot
8.2. Global Meloxicam Market by Population Type, Performance - Potential Analysis
8.3. Global Meloxicam Market Estimates & Forecasts by Population Type 2019-2028 (USD Billion)
8.4. Meloxicam Market, Sub Segment Analysis
8.4.1. Adult
8.4.2. Children
Chapter 9. Global Meloxicam Market, by Dosage
9.1. Market Snapshot
9.2. Global Meloxicam Market by Dosage, Performance - Potential Analysis
9.3. Global Meloxicam Market Estimates & Forecasts by Dosage 2019-2028 (USD Billion)
9.4. Meloxicam Market, Sub Segment Analysis
9.4.1. Oral
9.4.2. Parenteral
9.4.3. transdermal
9.4.4. Others
Chapter 10. Global Meloxicam Market, by Dose Strength
10.1. Market Snapshot
10.2. Global Meloxicam Market by Dose Strength, Performance - Potential Analysis
10.3. Global Meloxicam Market Estimates & Forecasts by Dose Strength2019-2028 (USD Billion)
10.4. Meloxicam Market, Sub Segment Analysis
10.4.1. 7.5mg
10.4.2. 15mg
10.4.3. Others
Chapter 11. Global Meloxicam Market, by End-Users
11.1. Market Snapshot
11.2. Global Meloxicam Market by End-Users, Performance - Potential Analysis
11.3. Global Meloxicam Market Estimates & Forecasts by End-Users2019-2028 (USD Billion)
11.4. Meloxicam Market, Sub Segment Analysis
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Home Healthcare
11.4.4. Others
Chapter 12. Global Meloxicam Market, by Distribution Channel
12.1. Market Snapshot
12.2. Global Meloxicam Market by Distribution Channel, Performance - Potential Analysis
12.3. Global Meloxicam Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)
12.4. Meloxicam Market, Sub Segment Analysis
12.4.1. Direct Tender
12.4.2. Hospital Pharmacy
12.4.3. Retail Pharmacy
12.4.4. Online Pharmacy
12.4.5. Others
Chapter 13. Global Meloxicam Market, Regional Analysis
13.1. Meloxicam Market, Regional Market Snapshot
13.2. North America Meloxicam Market
13.2.1. U.S. Meloxicam Market
13.2.1.1. Diseases breakdown estimates & forecasts, 2019-2028
13.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2028
13.2.1.3. Population Type breakdown estimates & forecasts, 2019-2028
13.2.1.4. Dosage breakdown estimates & forecasts, 2019-2028
13.2.1.5. Dose Strength breakdown estimates & forecasts, 2019-2028
13.2.1.6. End-Users breakdown estimates & forecasts, 2019-2028
13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2019-2028
13.2.2. Canada Meloxicam Market
13.3. Europe Meloxicam Market Snapshot
13.3.1. U.K. Meloxicam Market
13.3.2. Germany Meloxicam Market
13.3.3. France Meloxicam Market
13.3.4. Spain Meloxicam Market
13.3.5. Italy Meloxicam Market
13.3.6. Rest of Europe Meloxicam Market
13.4. Asia-Pacific Meloxicam Market Snapshot
13.4.1. China Meloxicam Market
13.4.2. India Meloxicam Market
13.4.3. Japan Meloxicam Market
13.4.4. Australia Meloxicam Market
13.4.5. South Korea Meloxicam Market
13.4.6. Rest of Asia Pacific Meloxicam Market
13.5. Latin America Meloxicam Market Snapshot
13.5.1. Brazil Meloxicam Market
13.5.2. Mexico Meloxicam Market
13.6. Rest of The World Meloxicam Market
Chapter 14. Competitive Intelligence
14.1. Top Market Strategies
14.2. Company Profiles
14.2.1. Taj Pharmaceutical Limited.
14.2.1.1. Key Information
14.2.1.2. Overview
14.2.1.3. Financial (Subject to Data Availability)
14.2.1.4. Product Summary
14.2.1.5. Recent Developments
14.2.2. Wellona Pharma
14.2.3. Trumac Healthcare
14.2.4. Healthy Life Pharma Private Limited.
14.2.5. EPICON LIFESCIENCES LLP
14.2.6. Boehringer Ingelheim GmbH.
14.2.7. Baudax Bio
14.2.8. Viatris Inc.
14.2.9. Avanstra Inc.
14.2.10. PD-Rx Pharmaceuticals, Inc.
Chapter 15. Research Process
15.1. Research Process
15.1.1. Data Mining
15.1.2. Analysis
15.1.3. Market Estimation
15.1.4. Validation
15.1.5. Publishing
15.2. Research Attributes
15.3. Research Assumption